Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 216261
Company: ALEMBIC PHARMS LTD
Company: ALEMBIC PHARMS LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DASATINIB | DASATINIB | 20mg | TABLET; ORAL | None (Tentative Approval) | None | No | No |
DASATINIB | DASATINIB | 50mg | TABLET; ORAL | None (Tentative Approval) | None | No | No |
DASATINIB | DASATINIB | 70mg | TABLET; ORAL | None (Tentative Approval) | None | No | No |
DASATINIB | DASATINIB | 80mg | TABLET; ORAL | None (Tentative Approval) | None | No | No |
DASATINIB | DASATINIB | 100mg | TABLET; ORAL | None (Tentative Approval) | None | No | No |
DASATINIB | DASATINIB | 140mg | TABLET; ORAL | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/09/2022 | ORIG-1 | Tentative Approval | STANDARD |
Label is not available on this site. |